Sustained activation of DNA damage response in irradiated apoptosis-resistant cells induces reversible senescence associated with mTOR downregulation and expression of stem cell markers

References

• Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006; 444:633 - 7; http://dx.doi.org/10.1038/nature05268; PMID: 17136093
   PubMed Web of Science ®Google Scholar
• Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88:593 - 602; http://dx.doi.org/10.1016/S0092-8674(00)81902-9; PMID: 9054499
   PubMed Web of Science ®Google Scholar
• Deng Q, Liao R, Wu BL, Sun P. High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts. J Biol Chem 2004; 279:1050 - 9; http://dx.doi.org/10.1074/jbc.M308644200; PMID: 14593117
   PubMed Web of Science ®Google Scholar
• te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 2002; 62:1876 - 83; PMID: 11912168
   PubMed Web of Science ®Google Scholar
• Robles SJ, Adami GR. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 1998; 16:1113 - 23; http://dx.doi.org/10.1038/sj.onc.1201862; PMID: 9528853
   PubMed Web of Science ®Google Scholar
• Munro J, Barr NI, Ireland H, Morrison V, Parkinson EK. Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock. Exp Cell Res 2004; 295:525 - 38; http://dx.doi.org/10.1016/j.yexcr.2004.01.017; PMID: 15093749
   PubMed Web of Science ®Google Scholar
• Rebbaa A, Zheng X, Chu F, Mirkin BL. The role of histone acetylation versus DNA damage in drug-induced senescence and apoptosis. Cell Death Differ 2006; 13:1960 - 7; http://dx.doi.org/10.1038/sj.cdd.4401895; PMID: 16557274
   PubMed Web of Science ®Google Scholar
• Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37:614 - 36; http://dx.doi.org/10.1016/0014-4827(65)90211-9; PMID: 14315085
   PubMed Web of Science ®Google Scholar
• Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995; 92:9363 - 7; http://dx.doi.org/10.1073/pnas.92.20.9363; PMID: 7568133
   PubMed Web of Science ®Google Scholar
• Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996; 16:859 - 67; PMID: 8622687
   PubMed Web of Science ®Google Scholar
• Rodier F, Coppé JP, Patil CK, Hoeijmakers WA, Muñoz DP, Raza SR, Freund A, Campeau E, Davalos AR, Campisi J. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 2009; 11:973 - 9; http://dx.doi.org/10.1038/ncb1909; PMID: 19597488
   PubMed Web of Science ®Google Scholar
• Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, Aarden LA, Mooi WJ, Peeper DS. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008; 133:1019 - 31; http://dx.doi.org/10.1016/j.cell.2008.03.039; PMID: 18555778
   PubMed Web of Science ®Google Scholar
• Adams PD. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 2007; 397:84 - 93; http://dx.doi.org/10.1016/j.gene.2007.04.020; PMID: 17544228
   PubMed Web of Science ®Google Scholar
• Narita M, Nũnez S, Heard E, Narita M, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113:703 - 16; http://dx.doi.org/10.1016/S0092-8674(03)00401-X; PMID: 12809602
   PubMed Web of Science ®Google Scholar
• Rodier F, Muñoz DP, Teachenor R, Chu V, Le O, Bhaumik D, Coppé JP, Campeau E, Beauséjour CM, Kim SH, et al. DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci 2011; 124:68 - 81; http://dx.doi.org/10.1242/jcs.071340; PMID: 21118958
   PubMed Web of Science ®Google Scholar
• Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002; 110:163 - 75; http://dx.doi.org/10.1016/S0092-8674(02)00808-5; PMID: 12150925
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004; 14:1296 - 302; http://dx.doi.org/10.1016/j.cub.2004.06.054; PMID: 15268862
   PubMed Web of Science ®Google Scholar
• Young AR, Narita M, Ferreira M, Kirschner K, Sadaie M, Darot JF, Tavaré S, Arakawa S, Shimizu S, Watt FM, et al. Autophagy mediates the mitotic senescence transition. Genes Dev 2009; 23:798 - 803; http://dx.doi.org/10.1101/gad.519709; PMID: 19279323
   PubMed Web of Science ®Google Scholar
• Jung CH, Ro SH, Cao J, Otto NM, Kim DH. mTOR regulation of autophagy. FEBS Lett 2010; 584:1287 - 95; http://dx.doi.org/10.1016/j.febslet.2010.01.017; PMID: 20083114
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging. Aging (Albany NY) 2012; 4:159 - 65; PMID: 22394614
   PubMedGoogle Scholar
• Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273:5858 - 68; http://dx.doi.org/10.1074/jbc.273.10.5858; PMID: 9488723
   PubMed Web of Science ®Google Scholar
• Rappold I, Iwabuchi K, Date T, Chen J. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J Cell Biol 2001; 153:613 - 20; http://dx.doi.org/10.1083/jcb.153.3.613; PMID: 11331310
   PubMed Web of Science ®Google Scholar
• Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421:499 - 506; http://dx.doi.org/10.1038/nature01368; PMID: 12556884
   PubMed Web of Science ®Google Scholar
• Thompson LH. Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: the molecular choreography. Mutat Res 2012; 751:158 - 246; http://dx.doi.org/10.1016/j.mrrev.2012.06.002; PMID: 22743550
   PubMed Web of Science ®Google Scholar
• Zou L. Single- and double-stranded DNA: building a trigger of ATR-mediated DNA damage response. Genes Dev 2007; 21:879 - 85; http://dx.doi.org/10.1101/gad.1550307; PMID: 17437994
   PubMed Web of Science ®Google Scholar
• Fernandez-Capetillo O, Chen HT, Celeste A, Ward I, Romanienko PJ, Morales JC, Naka K, Xia Z, Camerini-Otero RD, Motoyama N, et al. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol 2002; 4:993 - 7; http://dx.doi.org/10.1038/ncb884; PMID: 12447390
   PubMed Web of Science ®Google Scholar
• Jowsey P, Morrice NA, Hastie CJ, McLauchlan H, Toth R, Rouse J. Characterisation of the sites of DNA damage-induced 53BP1 phosphorylation catalysed by ATM and ATR. DNA Repair (Amst) 2007; 6:1536 - 44; http://dx.doi.org/10.1016/j.dnarep.2007.04.011; PMID: 17553757
   PubMed Web of Science ®Google Scholar
• Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre’ M, Nuciforo PG, Bensimon A, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444:638 - 42; http://dx.doi.org/10.1038/nature05327; PMID: 17136094
   PubMed Web of Science ®Google Scholar
• Noda A, Hirai Y, Hamasaki K, Mitani H, Nakamura N, Kodama Y. Unrepairable DNA double-strand breaks that are generated by ionising radiation determine the fate of normal human cells. J Cell Sci 2012; 125:5280 - 7; http://dx.doi.org/10.1242/jcs.101006; PMID: 22899723
   PubMed Web of Science ®Google Scholar
• d’Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003; 426:194 - 8; http://dx.doi.org/10.1038/nature02118; PMID: 14608368
   PubMed Web of Science ®Google Scholar
• Nakamura AJ, Chiang YJ, Hathcock KS, Horikawa I, Sedelnikova OA, Hodes RJ, Bonner WM. Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence. Epigenetics Chromatin 2008; 1:6; http://dx.doi.org/10.1186/1756-8935-1-6; PMID: 19014415
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57 - 70; http://dx.doi.org/10.1016/S0092-8674(00)81683-9; PMID: 10647931
   PubMed Web of Science ®Google Scholar
• Roninson IB, Broude EV, Chang BD. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 2001; 4:303 - 13; http://dx.doi.org/10.1054/drup.2001.0213; PMID: 11991684
   PubMed Web of Science ®Google Scholar
• Wang Q, Wu PC, Dong DZ, Ivanova I, Chu E, Zeliadt S, Vesselle H, Wu DY. Polyploidy road to therapy-induced cellular senescence and escape. Int J Cancer 2013; 132:1505 - 15; http://dx.doi.org/10.1002/ijc.27810; PMID: 22945332
   PubMed Web of Science ®Google Scholar
• Cao K, Graziotto JJ, Blair CD, Mazzulli JR, Erdos MR, Krainc D, Collins FS. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci Transl Med 2011; 3:89ra58; http://dx.doi.org/10.1126/scitranslmed.3002346; PMID: 21715679
   PubMed Web of Science ®Google Scholar
• Pospelova TV, Leontieva OV, Bykova TV, Zubova SG, Pospelov VA, Blagosklonny MV. Suppression of replicative senescence by rapamycin in rodent embryonic cells. Cell Cycle 2012; 11:2402 - 7; http://dx.doi.org/10.4161/cc.20882; PMID: 22672902
   PubMed Web of Science ®Google Scholar
• Beauséjour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, Campisi J. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 2003; 22:4212 - 22; http://dx.doi.org/10.1093/emboj/cdg417; PMID: 12912919
   PubMed Web of Science ®Google Scholar
• Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988; 334:124 - 9; http://dx.doi.org/10.1038/334124a0; PMID: 2968522
   PubMed Web of Science ®Google Scholar
• Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991; 65:1053 - 61; http://dx.doi.org/10.1016/0092-8674(91)90557-F; PMID: 1828392
   PubMed Web of Science ®Google Scholar
• Bagchi S, Raychaudhuri P, Nevins JR. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell 1990; 62:659 - 69; http://dx.doi.org/10.1016/0092-8674(90)90112-R; PMID: 2143697
   PubMed Web of Science ®Google Scholar
• Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 1992; 6:177 - 85; http://dx.doi.org/10.1101/gad.6.2.177; PMID: 1531329
   PubMed Web of Science ®Google Scholar
• Johnson DG, Schwarz JK, Cress WD, Nevins JR. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 1993; 365:349 - 52; http://dx.doi.org/10.1038/365349a0; PMID: 8377827
   PubMed Web of Science ®Google Scholar
• Sedelnikova OA, Pilch DR, Redon C, Bonner WM. Histone H2AX in DNA damage and repair. Cancer Biol Ther 2003; 2:233 - 5; http://dx.doi.org/10.4161/cbt.2.3.373; PMID: 12878854
   PubMed Web of Science ®Google Scholar
• Fumagalli M, Rossiello F, Clerici M, Barozzi S, Cittaro D, Kaplunov JM, Bucci G, Dobreva M, Matti V, Beausejour CM, et al. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat Cell Biol 2012; 14:355 - 65; http://dx.doi.org/10.1038/ncb2466; PMID: 22426077
   PubMed Web of Science ®Google Scholar
• Olive PL, Banáth JP, Durand RE. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the “comet” assay. 1990. Radiat Res 2012; 178:AV35 - 42; http://dx.doi.org/10.1667/RRAV04.1; PMID: 22870978
   PubMed Web of Science ®Google Scholar
• Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988; 175:184 - 91; http://dx.doi.org/10.1016/0014-4827(88)90265-0; PMID: 3345800
   PubMed Web of Science ®Google Scholar
• d’Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 2008; 8:512 - 22; http://dx.doi.org/10.1038/nrc2440; PMID: 18574463
   PubMed Web of Science ®Google Scholar
• Pospelova TV, Demidenko ZN, Bukreeva EI, Pospelov VA, Gudkov AV, Blagosklonny MV. Pseudo-DNA damage response in senescent cells. Cell Cycle 2009; 8:4112 - 8; http://dx.doi.org/10.4161/cc.8.24.10215; PMID: 19946210
   PubMed Web of Science ®Google Scholar
• Dimauro T, David G. Chromatin modifications: the driving force of senescence and aging?. Aging (Albany NY) 2009; 1:182 - 90; PMID: 20157508
   PubMedGoogle Scholar
• Kosar M, Bartkova J, Hubackova S, Hodny Z, Lukas J, Bartek J. Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a). Cell Cycle 2011; 10:457 - 68; http://dx.doi.org/10.4161/cc.10.3.14707; PMID: 21248468
   PubMed Web of Science ®Google Scholar
• Menendez JA, Vellon L, Oliveras-Ferraros C, Cufí S, Vazquez-Martin A. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging. Cell Cycle 2011; 10:3658 - 77; http://dx.doi.org/10.4161/cc.10.21.18128; PMID: 22052357
   PubMed Web of Science ®Google Scholar
• Pospelova TV, Bykova TV, Zubova SG, Katolikova NV, Yartzeva NM, Pospelov VA. Rapamycin induces pluripotent genes associated with avoidance of replicative senescence. Cell Cycle 2013; 12:3841 - 51; http://dx.doi.org/10.4161/cc.27396; PMID: 24296616
   PubMed Web of Science ®Google Scholar
• Salmina K, Jankevics E, Huna A, Perminov D, Radovica I, Klymenko T, Ivanov A, Jascenko E, Scherthan H, Cragg M, et al. Up-regulation of the embryonic self-renewal network through reversible polyploidy in irradiated p53-mutant tumour cells. Exp Cell Res 2010; 316:2099 - 112; http://dx.doi.org/10.1016/j.yexcr.2010.04.030; PMID: 20457152
   PubMed Web of Science ®Google Scholar
• Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, Barrett JC. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol 2004; 6:168 - 70; http://dx.doi.org/10.1038/ncb1095; PMID: 14755273
   PubMed Web of Science ®Google Scholar
• Mallette FA, Gaumont-Leclerc MF, Ferbeyre G. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev 2007; 21:43 - 8; http://dx.doi.org/10.1101/gad.1487307; PMID: 17210786
   PubMed Web of Science ®Google Scholar
• Murga M, Jaco I, Fan Y, Soria R, Martinez-Pastor B, Cuadrado M, Yang SM, Blasco MA, Skoultchi AI, Fernandez-Capetillo O. Global chromatin compaction limits the strength of the DNA damage response. J Cell Biol 2007; 178:1101 - 8; http://dx.doi.org/10.1083/jcb.200704140; PMID: 17893239
   PubMed Web of Science ®Google Scholar
• Comai L. The advantages and disadvantages of being polyploid. Nat Rev Genet 2005; 6:836 - 46; http://dx.doi.org/10.1038/nrg1711; PMID: 16304599
   PubMed Web of Science ®Google Scholar
• Duelli D, Lazebnik Y. Cell fusion: a hidden enemy?. Cancer Cell 2003; 3:445 - 8; http://dx.doi.org/10.1016/S1535-6108(03)00114-4; PMID: 12781362
   PubMed Web of Science ®Google Scholar
• Zheng L, Dai H, Zhou M, Li X, Liu C, Guo Z, Wu X, Wu J, Wang C, Zhong J, et al. Polyploid cells rewire DNA damage response networks to overcome replication stress-induced barriers for tumour progression. Nat Commun 2012; 3:815; http://dx.doi.org/10.1038/ncomms1825; PMID: 22569363
   PubMed Web of Science ®Google Scholar
• Braunstein S, Badura ML, Xi Q, Formenti SC, Schneider RJ. Regulation of protein synthesis by ionizing radiation. Mol Cell Biol 2009; 29:5645 - 56; http://dx.doi.org/10.1128/MCB.00711-09; PMID: 19704005
   PubMed Web of Science ®Google Scholar
• Feng Z, Zhang H, Levine AJ, Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci U S A 2005; 102:8204 - 9; http://dx.doi.org/10.1073/pnas.0502857102; PMID: 15928081
   PubMed Web of Science ®Google Scholar
• Alexander A, Cai SL, Kim J, Nanez A, Sahin M, MacLean KH, Inoki K, Guan KL, Shen J, Person MD, et al. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A 2010; 107:4153 - 8; http://dx.doi.org/10.1073/pnas.0913860107; PMID: 20160076
   PubMed Web of Science ®Google Scholar
• Demidenko ZN, Korotchkina LG, Gudkov AV, Blagosklonny MV. Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci U S A 2010; 107:9660 - 4; http://dx.doi.org/10.1073/pnas.1002298107; PMID: 20457898
   PubMed Web of Science ®Google Scholar
• Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, Blagosklonny MV. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY) 2010; 2:344 - 52; PMID: 20606252
   PubMedGoogle Scholar
• Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV, Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell Cycle 2009; 8:1888 - 95; http://dx.doi.org/10.4161/cc.8.12.8606; PMID: 19471117
   PubMed Web of Science ®Google Scholar
• Kolesnichenko M, Hong L, Liao R, Vogt PK, Sun P. Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence. Cell Cycle 2012; 11:2391 - 401; http://dx.doi.org/10.4161/cc.20683; PMID: 22627671
   PubMed Web of Science ®Google Scholar
• Chen T, Shen L, Yu J, Wan H, Guo A, Chen J, Long Y, Zhao J, Pei G. Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells. Aging Cell 2011; 10:908 - 11; http://dx.doi.org/10.1111/j.1474-9726.2011.00722.x; PMID: 21615676
   PubMed Web of Science ®Google Scholar
• Feng B, Ng JH, Heng JC, Ng HH. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 2009; 4:301 - 12; http://dx.doi.org/10.1016/j.stem.2009.03.005; PMID: 19341620
   PubMed Web of Science ®Google Scholar
• González F, Georgieva D, Vanoli F, Shi ZD, Stadtfeld M, Ludwig T, Jasin M, Huangfu D. Homologous recombination DNA repair genes play a critical role in reprogramming to a pluripotent state. Cell Rep 2013; 3:651 - 60; http://dx.doi.org/10.1016/j.celrep.2013.02.005; PMID: 23478019
   PubMed Web of Science ®Google Scholar
• Fong YW, Inouye C, Yamaguchi T, Cattoglio C, Grubisic I, Tjian R. A DNA repair complex functions as an Oct4/Sox2 coactivator in embryonic stem cells. Cell 2011; 147:120 - 31; http://dx.doi.org/10.1016/j.cell.2011.08.038; PMID: 21962512
   PubMed Web of Science ®Google Scholar
• Molina-Estevez FJ, Lozano ML, Navarro S, Torres Y, Grabundzija I, Ivics Z, Samper E, Bueren JA, Guenechea G. Brief report: impaired cell reprogramming in nonhomologous end joining deficient cells. Stem Cells 2013; 31:1726 - 30; http://dx.doi.org/10.1002/stem.1406; PMID: 23630174
   PubMed Web of Science ®Google Scholar
• Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J, et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006; 38:431 - 40; http://dx.doi.org/10.1038/ng1760; PMID: 16518401
   PubMed Web of Science ®Google Scholar
• Noh KH, Kim BW, Song KH, Cho H, Lee YH, Kim JH, Chung JY, Kim JH, Hewitt SM, Seong SY, et al. Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J Clin Invest 2012; 122:4077 - 93; http://dx.doi.org/10.1172/JCI64057; PMID: 23093782
   PubMed Web of Science ®Google Scholar
• Jeter CR, Liu B, Liu X, Chen X, Liu C, Calhoun-Davis T, Repass J, Zaehres H, Shen JJ, Tang DG. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 2011; 30:3833 - 45; http://dx.doi.org/10.1038/onc.2011.114; PMID: 21499299
   PubMed Web of Science ®Google Scholar
• Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 2010; 70:10433 - 44; http://dx.doi.org/10.1158/0008-5472.CAN-10-2638; PMID: 21159654
   PubMed Web of Science ®Google Scholar
• Chang CC, Shieh GS, Wu P, Lin CC, Shiau AL, Wu CL. Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res 2008; 68:6281 - 91; http://dx.doi.org/10.1158/0008-5472.CAN-08-0094; PMID: 18676852
   PubMed Web of Science ®Google Scholar
• Lu X, Mazur SJ, Lin T, Appella E, Xu Y. The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. Oncogene 2013; PMID: 23770853
   PubMed Web of Science ®Google Scholar
• Watanabe M, Ohnishi Y, Inoue H, Wato M, Tanaka A, Kakudo K, Nozaki M. NANOG expression correlates with differentiation, metastasis and resistance to preoperative adjuvant therapy in oral squamous cell carcinoma. Oncol Lett 2014; 7:35 - 40; PMID: 24348816
   PubMed Web of Science ®Google Scholar
• Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008; 40:499 - 507; http://dx.doi.org/10.1038/ng.127; PMID: 18443585
   PubMed Web of Science ®Google Scholar
• Erenpreisa J, Salmina K, Huna A, Kosmacek EA, Cragg MS, Ianzini F, Anisimov AP. Polyploid tumour cells elicit paradiploid progeny through depolyploidizing divisions and regulated autophagic degradation. Cell Biol Int 2011; 35:687 - 95; http://dx.doi.org/10.1042/CBI20100762; PMID: 21250945
   PubMed Web of Science ®Google Scholar
• Puig PE, Guilly MN, Bouchot A, Droin N, Cathelin D, Bouyer F, Favier L, Ghiringhelli F, Kroemer G, Solary E, et al. Tumor cells can escape DNA-damaging cisplatin through DNA endoreduplication and reversible polyploidy. Cell Biol Int 2008; 32:1031 - 43; http://dx.doi.org/10.1016/j.cellbi.2008.04.021; PMID: 18550395
   PubMed Web of Science ®Google Scholar
• Martin F, Puig PE, Ghiringhelli F, Chauffert B. DNA-damaged polyploid cancer cells can reverse to diploidy: an ordered, but little understood, process of genomic reduction [with reference to the previous comments of Forer (2008) and Wheatley (2008a and b)]. [with reference to the previous comments of Forer (2008) and Wheatley (2008a and b)] Cell Biol Int 2009; 33:702 - 3; http://dx.doi.org/10.1016/j.cellbi.2009.02.016; PMID: 19303938
   PubMed Web of Science ®Google Scholar
• Pospelova TV, Chitikova ZV, Pospelov VA. An integrated approach for monitoring cell senescence. Methods Mol Biol 2013; 965:383 - 408; http://dx.doi.org/10.1007/978-1-62703-239-1_26; PMID: 23296673
   PubMedGoogle Scholar